Ardelyx, Inc. · 20 hours ago
Director, Field Access and Reimbursement - West
United States
Full-time
Hybrid
Director/Executive
$223K/yr - $273K/yr
10+ years expArdelyx, Inc. is a publicly traded commercial biopharmaceutical company focused on innovative medicines. The Director, Field Access and Reimbursement is responsible for strategic leadership and operational oversight of field reimbursement managers to ensure patient access to company products and resolve access barriers.
BiotechnologyHealth CareMedical
Responsibilities
Hire, train, and develop a high performing FRM team to engage with customers about access and reimbursement challenges and resolve patient cases
Ensure understanding of performance metrics and consistent execution of metrics across all team members
Motivate the FRM team to build strong customer relationships, provide education for the Ardelyx patient assistance services, and compliantly deliver reimbursement support to accounts
Coach team members to ensure maximum performance, increase access and reimbursement acumen, and collaborate with sales counterparts
Ensure all team activities strictly comply with all regulatory, legal, and compliance standards, including HIPAA and OIG guidelines
Develop and execute an overarching field access and reimbursement strategy for the assigned region, aligning plans with brand priorities and corporate objectives to drive measurable outcomes and maximize patient access
Partner closely with Market Access, Sales, Marketing, Medical Affairs, Legal, and Patient Support Hub teams to ensure seamless execution and alignment of strategies
Oversee the team's efforts to proactively educate providers and office staff on patient support programs, coding, billing, and prior authorization requirements to help resolve reimbursement challenges and integrate product use into office workflows
Oversee the team's efforts to proactively educate providers and office staff on patient support programs, coding, billing, and prior authorization requirements to help resolve reimbursement challenges and integrate product use into office workflows
Maintain deep expertise in the dynamic regional and local access and payer landscape (Commercial, Medicare, Medicaid), anticipating changes in healthcare policy and reimbursement regulations that may impact product access
Train FRMs about technical policies, systems, and processes that impact access to Ardelyx products
Qualification
Required
Bachelor's degree, Master's degree preferred, with 10+ years of progressive experience in field reimbursement, patient services, market access, or related functions within the pharmaceutical/biotech industry or equivalent experience
3+ years of experience as an Access and Reimbursement Manager or 3 years of field based first line leader experience
Demonstrated ability to lead without direct authority and drive momentum in a highly matrixed environment
Exceptional problem-solving, analytical, strategic thinking, and communication skills, with the ability to present complex information to C-level account executives and internal leadership
In depth experience navigating payer policies and knowledge of payer processes and systems for specialty products
Deep understanding of both medical and pharmacy benefits, coverage policies, buy-and-bill, and specialty pharmacy reimbursement pathways
Demonstrated leadership in a matrixed environment
Valid driver's license required
Benefits
401(k) plan with generous employer match
12 weeks of paid parental leave
Up to 12 weeks of living organ and bone marrow leave
Equity incentive plans
Health plans (medical, prescription drug, dental, and vision)
Life insurance and disability
Flexible time off
Annual Winter Holiday shut down
At least 11 paid holidays
Company
Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$557.68MKey Investors
HealthCare Royalty PartnersSLR Capital PartnersNew Enterprise Associates
2022-06-30Post Ipo Debt· $20M
2022-02-24Post Ipo Debt· $27.5M
2019-12-12Post Ipo Equity· $125M
Leadership Team
Mike Raab
President & CEO
Elizabeth Grammer
Chief Legal and Administrative Officer
Recent News
2026-01-20
2026-01-20
2026-01-09
Company data provided by crunchbase